NYSE American - Delayed Quote USD

Scorpius Holdings, Inc. (SCPX)

0.0777 +0.0009 (+1.17%)
At close: 4:00 PM EDT
0.0840 +0.01 (+8.11%)
After hours: 6:17 PM EDT
Loading Chart for SCPX
DELL
  • Previous Close 0.0768
  • Open 0.0832
  • Bid 0.0845 x 900
  • Ask 0.0830 x 1200
  • Day's Range 0.0775 - 0.0863
  • 52 Week Range 0.0700 - 0.8900
  • Volume 9,991,931
  • Avg. Volume 997,096
  • Market Cap (intraday) 6.616M
  • Beta (5Y Monthly) 0.03
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 15, 2024 - May 17, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

www.scorpiusbiologics.com

82

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SCPX

Performance Overview: SCPX

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SCPX
82.34%
S&P 500
11.29%

1-Year Return

SCPX
88.74%
S&P 500
28.71%

3-Year Return

SCPX
98.69%
S&P 500
27.18%

5-Year Return

SCPX
98.77%
S&P 500
87.28%

Compare To: SCPX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SCPX

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    2.77M

  • Enterprise Value

    14.42M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.29

  • Price/Book (mrq)

    0.09

  • Enterprise Value/Revenue

    2.06

  • Enterprise Value/EBITDA

    -0.27

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -33.80%

  • Return on Equity (ttm)

    -82.92%

  • Revenue (ttm)

    6.99M

  • Net Income Avi to Common (ttm)

    -40.15M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.39M

  • Total Debt/Equity (mrq)

    49.63%

  • Levered Free Cash Flow (ttm)

    -18.56M

Research Analysis: SCPX

Company Insights: SCPX

Research Reports: SCPX

People Also Watch